Dr. ID: 6016847
Corinna Albers-Leischner
Publications
- 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis
Illini, O., Saalfeld, F. C., Christopoulos, P., Duruisseaux, M., Vikström, A., Peled, N., Demedts, I., Dudnik, E., Eisert, A., Hashemi, S. M. S., Janzic, U., Kian, W., Mohorcic, K., Mohammed, S., Silvoniemi, M., Rothschild, S. I., Schulz, C., Wesseler, C., Addeo, A., Armster, K., Itchins, M., Ivanović, M., Kauffmann-Guerrero, D., Koivunen, J., Kuon, J., Pavlakis, N., Piet, B., Sebastian, M., Velthaus-Rusik, J-L., Wannesson, L., Wiesweg, M., Wurm, R., Albers-Leischner, C., Aust, D. E., Janning, M., Fabikan, H., Herold, S., Klimova, A., Loges, S., Sharapova, Y., Schütz, M., Weinlinger, C., Valipour, A., Overbeck, T. R., Griesinger, F., Jakopovic, M., Hochmair, M. J. & Wermke, M., 03.04.2024, In: INT J MOL SCI. 25, 7, 3992.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)
Janning, M., Süptitz, J., Albers-Leischner, C., Delpy, P., Tufman, A., Velthaus-Rusik, J-L., Reck, M., Jung, A., Kauffmann-Guerrero, D., Bonzheim, I., Brändlein, S., Hummel, H-D., Wiesweg, M., Schildhaus, H-U., Stratmann, J. A., Sebastian, M., Alt, J., Buth, J., Esposito, I., Berger, J., Tögel, L., Saalfeld, F. C., Wermke, M., Merkelbach-Bruse, S., Hillmer, A. M., Klauschen, F., Bokemeyer, C., Buettner, R., Wolf, J. & Loges, S., 06.2022, In: ANN ONCOL. 33, 6, p. 602-615 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis
Kreutmair, S., Lippert, L. J., Klingeberg, C., Albers-Leischner, C., Yacob, S., Shlyakhto, V., Mueller, T., Mueller-Rudorf, A., Yu, C., Gorantla, S. P., Miething, C., Duyster, J. & Illert, A. L., 13.05.2022, In: FRONT ONCOL. 12, 875117.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2020
Phosphorylation of Beclin-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
Yu, C., Gorantla, S. P., Müller-Rudorf, A., Müller, T. A., Kreutmair, S., Albers, C., Jakob, L., Lippert, L. J., Yue, Z., Engelhardt, M., Follo, M., Zeiser, R., Huber, T. B., Duyster, J. & Illert, A. L., 05.2020, In: HAEMATOLOGICA. 105, 5, p. 1285-1293 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2015
Grb10 is involved in BCR-ABL-positive leukemia in mice
Illert, A. L., Albers, C., Kreutmair, S., Leischner, H., Peschel, C., Miething, C. & Duyster, J., 04.2015, In: LEUKEMIA. 29, 4, p. 858-68 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2014
GP130 activation induces myeloma and collaborates with MYC
Dechow, T., Steidle, S., Götze, K. S., Rudelius, M., Behnke, K., Pechloff, K., Kratzat, S., Bullinger, L., Fend, F., Soberon, V., Mitova, N., Li, Z., Thaler, M., Bauer, J., Pietschmann, E., Albers, C., Grundler, R., Schmidt-Supprian, M., Ruland, J., Peschel, C., Duyster, J., Rose-John, S., Bassermann, F. & Keller, U., 12.2014, In: J CLIN INVEST. 124, 12, p. 5263-74 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2013
The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib
Albers, C., Leischner, H., Verbeek, M., Yu, C., Illert, A. L., Peschel, C., von Bubnoff, N. & Duyster, J., 06.2013, In: LEUKEMIA. 27, 6, p. 1416-8 3 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2012
Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M
Illert, A. L., Zech, M., Moll, C., Albers, C., Kreutmair, S., Peschel, C., Bassermann, F. & Duyster, J., 02.11.2012, In: J BIOL CHEM. 287, 45, p. 37997-8005 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML
Leischner, H., Albers, C., Grundler, R., Razumovskaya, E., Spiekermann, K., Bohlander, S., Rönnstrand, L., Götze, K., Peschel, C. & Duyster, J., 26.04.2012, In: BLOOD. 119, 17, p. 4026-33 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2011
An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL-driven leukemogenesis
Albers, C., Illert, A. L., Miething, C., Leischner, H., Thiede, M., Peschel, C. & Duyster, J., 25.08.2011, In: BLOOD. 118, 8, p. 2200-10 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease
Hartmann, N., Leithäuser, F., Albers, C., Duyster, J., Möller, P., Debatin, K-M. & Strauss, G., 05.2011, In: LEUKEMIA. 25, 5, p. 848-55 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2010
Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway
Markova, B., Albers, C., Breitenbuecher, F., Melo, J. V., Brümmendorf, T. H., Heidel, F., Lipka, D., Duyster, J., Huber, C. & Fischer, T., 04.02.2010, In: ONCOGENE. 29, 5, p. 739-51 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review